FINSMES reports Pfizer has invested $51 million for a 15% stake in Vivet Therapeutics, a France-based gene therapy venture dedicated to developing inherited liver disorder treatments.  Pfizer secured an exclusive option to buy all outstanding shares. Pfizer’s Monika...